Among them, we found that a compound, named BW18, can induce S-phase cell cycle arrest and apoptosis via the mitogen-activated protein kinase (MAPK) pathway in human chronic myeloid leukemia K562 cells. Here, WNK2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.